janssen covid-19 vaccine
integrated healthcare indonesia - indonesia - recombinant novel adenovirus (ad-26) vector-sars-cov-2 - suspensi injeksi - nlt 2.5 x 10^10 vp, nlt 8.92 log10 iu
janssen covid-19 vaccine
integrated healthcare indonesia - indonesia - recombinant novel adenovirus (ad-26) vector-sars-cov-2 - suspensi injeksi - nlt 2.5 x 10^10 vp, nlt 8.92 log10 iu
covid-19 vaccine astrazeneca
astrazeneca indonesia - indonesia - recombinant adenovirus (chadox1) vector-sars-cov-2 - larutan injeksi - 5 x 10^10 vp
janssen covid-19 vaccine
integrated healthcare indonesia - indonesia - recombinant novel adenovirus (ad-26) vector-sars-cov-2 - suspensi injeksi - nlt 2.5 x 10^10 vp, nlt 8.92 log10 iu
covid-19 vaccine astrazeneca
astrazeneca indonesia - indonesia - recombinant adenovirus (chadox1) vector-sars-cov-2 - larutan injeksi - 5 x 10^10 vp
covid-19 vaccine astrazeneca
astrazeneca indonesia - indonesia - recombinant adenovirus (chadox1) vector-sars-cov-2 - larutan injeksi - 5 x 10^10 vp
covid-19 vaccine astrazeneca
astrazeneca indonesia - indonesia - recombinant adenovirus (chadox1) vector-sars-cov-2 - larutan injeksi - 5 x 10^10 vp
covid-19 vaccine astrazeneca
astrazeneca indonesia - indonesia - recombinant adenovirus (chadox1) vector-sars-cov-2 - larutan injeksi - 5 x 10^10 vp
covid-19 vaccine astrazeneca
astrazeneca indonesia - indonesia - recombinant adenovirus (chadox1) vector-sars-cov-2 - larutan injeksi - 5 x 10^10 vp
covid-19 vaccine astrazeneca
astrazeneca indonesia - indonesia - recombinant adenovirus (chadox1) vector-sars-cov-2 - larutan injeksi - 5 x 10^10 vp